Mumbai-based B2B pharma distribution startup Fundly.ai has raised $4 million in a funding round led by existing investors Accel and Multiply Ventures
Shashank Pathak08 Sep 2026
10:08IST
New Update
Mumbai-based B2B pharma distribution startup Fundly.ai has raised $4 million in a funding round led by existing investors Accel and Multiply Ventures, along with participation from former RBL Bank executive director Rajeev Ahuja and other angel investors.
The company also raised around $0.9 million in venture debt.
The fresh capital will be used to expand its digital commerce, payments and credit offerings across India’s pharma supply chain.
Founded in 2021 by Amit Chawla and Shreeram Ramanathan, Fundly.ai initially started as a supply-chain financing platform for pharma businesses. It has since expanded into three areas: B2B commerce, payments and settlement infrastructure, and embedded credit.
Fundly aims to help pharma retailers and distributors manage procurement, payments and working capital through a single technology platform.
The latest round builds on Fundly.ai’s earlier $3 million seed funding in 2023, which was also led by Accel with participation from Multiply Ventures and angel investors.
Bareback Media has recently raised funding from a group of investors. Some of the investors may directly or indirectly be involved in a competing business or might be associated with other companies we might write about. This shall, however, not influence our reporting or coverage in any manner whatsoever. You may find a list of our investors here.
